Jeffrey W Albers's Net Worth
Jeffrey W Albers's net worth is estimated to be at least $43,429,643.44 as of 12/23/2024. CoreStreet's estimation of Jeffrey W Albers's net worth is based on their sale of stock and current holding of stock.
Jeffrey W Albers is Director at Blueprint Medicines Corp. They have executed at least 40 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,000 units of BPMC stock on 12/19/2024. Their biggest sale was on 11/15/2021 when they sold 30,000 units of Blueprint Medicines Corp stock for $3,435,000.00. They typically trade 4 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $43,429,643.44
Most recent insider trade:
- Dec. 19, 2024
Jeffrey W Albers's Insider Trading History
| Blueprint Medicines Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 19, 2024 | Director | 15,000 | $89.77 | Sell | $1,346,550.00 |
March 20, 2024 | Director | 25,073 | $87.28 | Sell | $2,188,371.44 |
Jan. 25, 2024 | Director | 25,000 | $81.91 | Sell | $2,047,750.00 |
Nov. 30, 2023 | Director | 5,000 | $70.55 | Sell | $352,750.00 |
Nov. 24, 2023 | Director | 15,000 | $67.51 | Sell | $1,012,650.00 |
Nov. 3, 2023 | Director | 1,485 | $60.13 | Sell | $89,293.05 |
Nov. 1, 2023 | Director | 3,881 | $60.02 | Sell | $232,937.62 |
Sept. 28, 2023 | Director | 6,898 | $50.17 | Sell | $346,072.66 |
Aug. 25, 2023 | Director | 10,000 | $50.16 | Sell | $501,600.00 |
March 6, 2023 | Director | 9,793 | $45.67 | Sell | $447,246.31 |
Dec. 5, 2022 | Director | 20,000 | $50.09 | Sell | $1,001,800.00 |
Aug. 22, 2022 | Director | 8,410 | $70.54 | Sell | $593,241.40 |
Aug. 19, 2022 | Director | 1,590 | $70.02 | Sell | $111,331.80 |
Aug. 16, 2022 | Director | 20,000 | $68.41 | Sell | $1,368,200.00 |
Aug. 8, 2022 | Director | 10,000 | $70.07 | Sell | $700,700.00 |
April 6, 2022 | CEO | 5,000 | $70.11 | Sell | $350,550.00 |
Nov. 15, 2021 | CEO | 30,000 | $114.50 | Sell | $3,435,000.00 |
Aug. 19, 2021 | CEO | 25,000 | $92.68 | Sell | $2,317,000.00 |
May 12, 2021 | CEO | 25,000 | $92.69 | Sell | $2,317,250.00 |
Oct. 7, 2020 | CEO | 5,000 | $99.17 | Sell | $495,850.00 |
May 12, 2020 | CEO | 20,000 | $64.67 | Sell | $1,293,400.00 |
March 23, 2020 | CEO | 20,000 | $52.10 | Sell | $1,042,000.00 |
Nov. 18, 2019 | CEO | 8,256 | $75.42 | Sell | $622,667.52 |
Nov. 8, 2019 | CEO | 11,744 | $74.56 | Sell | $875,632.64 |
Aug. 19, 2019 | CEO | 20,000 | $81.73 | Sell | $1,634,600.00 |
June 17, 2019 | CEO | 5,000 | $99.06 | Sell | $495,300.00 |
June 12, 2019 | CEO | 20,000 | $84.75 | Sell | $1,695,000.00 |
March 15, 2019 | CEO | 20,000 | $86.39 | Sell | $1,727,800.00 |
Nov. 5, 2018 | CEO | 20,000 | $63.49 | Sell | $1,269,800.00 |
Aug. 6, 2018 | CEO | 20,000 | $70.59 | Sell | $1,411,800.00 |
May 7, 2018 | CEO | 20,000 | $78.90 | Sell | $1,578,000.00 |
March 2, 2018 | CEO | 20,000 | $92.57 | Sell | $1,851,400.00 |
Nov. 6, 2017 | CEO | 30,000 | $70.31 | Sell | $2,109,300.00 |
Aug. 8, 2017 | CEO | 30,000 | $49.62 | Sell | $1,488,600.00 |
Aug. 7, 2017 | CEO | 20,000 | $49.08 | Sell | $981,600.00 |
June 28, 2017 | CEO | 20,000 | $50.47 | Sell | $1,009,400.00 |
Aug. 8, 2016 | CEO | 17,000 | $22.86 | Sell | $388,620.00 |
June 3, 2016 | CEO | 17,000 | $20.03 | Sell | $340,510.00 |
April 6, 2016 | CEO | 17,000 | $20.42 | Sell | $347,140.00 |
| Spyre Therapeutics Inc. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 25, 2024 | Director | 300 | $36.43 | Sell | $10,929.00 |